Ofatumumab - a valid treatment option for chronic lymphocytic leukemia patients

AlDallal, SM

AlDallal, SM (reprint author), Amiri Hosp, Haematol Lab, Kuwait 150300, Kuwait.

THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017; 13 ( ): 905

Abstract

Ofatumumab Arzerra (R) is a human monoclonal antibody, which induces killing of a panel of tumor B-cell lines and primary tumor cells by the activatio......

Full Text Link